R. Brian McKernan
Directeur Général chez The Courtagen Group LLC
Profil
R.
Brian McKernan is the founder of Agencourt Personal Genomics (founded in 2005), Courtagen Life Sciences, Inc. (founded in 1999), Agencourt Bioscience Corp.
(founded in 2000), and The Courtagen Group LLC (founded in 2005).
He holds the title of Chief Executive Officer at Courtagen Life Sciences, Inc. from 1999 to 2013, Chief Executive Officer at Agencourt Bioscience Corp.
from 2000 to 2009, and was previously the Chief Executive Officer at The Courtagen Group LLC.
Mr. McKernan is also the founder of StructuredMarkets, Inc. Mr. McKernan's current jobs include being a Director at Nusano, Inc. and a Member at Analytical Life Science & Diagnostics Association.
His former jobs include being the Chief Executive Officer at General Re Corp.
and a Manager at Deloitte Consulting LLP.
Mr. McKernan's education includes an undergraduate degree from Bucknell University and an MBA from Columbia Business School.
Postes actifs de R. Brian McKernan
| Sociétés | Poste | Début |
|---|---|---|
The Courtagen Group LLC
 The Courtagen Group LLC Investment ManagersFinance Courtagen Group LLC is a venture capital firm located in Charlestown, Massachusetts. | Directeur Général | 01/01/2005 |
| Analytical Life Science & Diagnostics Association | Corporate Officer/Principal | - |
Nusano, Inc.
 Nusano, Inc. Medical SpecialtiesHealth Technology Nusano, Inc. is a privately held medical technology company that is committed to bringing stability and innovation to the medical radioisotopes market. The company is based in Valencia, CA. The company's proprietary ion source is smaller and more efficient than existing production methods, which allows for the simultaneous manufacturing of multiple radioisotopes. Nusano's state-of-the-art production facility will open in the first quarter of 2025. The company's technologies will supply the fight against cancer and support diagnostic and therapeutic radiopharmaceutical development. Christopher P. Lowe has been the CEO of the company since 2022. | Directeur/Membre du Conseil | - |
Anciens postes connus de R. Brian McKernan
| Sociétés | Poste | Fin |
|---|---|---|
Agencourt Bioscience Corp.
 Agencourt Bioscience Corp. Miscellaneous Commercial ServicesCommercial Services Agencourt Bioscience Corp. provides genomic services and nucleic acid purification products. Its services enable biotechnology, pharmaceutical, government, and academic research laboratories to develop new drugs. The company was founded in July, 2000 by R. Brian McKernan, Kevin J. McKernan, and Brendan L. McKernan and is headquartered in Beverly, MA | Directeur Général | 31/12/2009 |
Agencourt Personal Genomics
 Agencourt Personal Genomics Medical SpecialtiesHealth Technology Part of Applied Biosystems, Inc., Agencourt Personal Genomics develops genetic analysis technologies. The company is based in Beverly, MA. The company was founded by Brendan L. McKernan, R. Brian McKernan, Kevin J. McKernan. Agencourt Personal Genomics was acquired by Applied Biosystems, Inc. /Old/ from Beckman Coulter, Inc. on July 11, 2006 for $120 million. | Fondateur | - |
Courtagen Life Sciences, Inc.
 Courtagen Life Sciences, Inc. Electronic Equipment/InstrumentsElectronic Technology Courtagen Life Sciences, Inc. provides proteomic and genomic products and services to the life sciences industry. It offers clinical genetic tests for developmental delay, intellectual disability, autism spectrum disorders, epilepsy and seizure disorders and mitochondrial disorders. The company was founded by Jocelyn W. Burke, Elizabeth Holland, Brendan L. McKernan, Kevin J. McKernan, Brian R. McKernan and Timothy Olcott in 1999 and is headquartered in Woburn, MA. | Fondateur | - |
Deloitte Consulting LLP
 Deloitte Consulting LLP Miscellaneous Commercial ServicesCommercial Services Deloitte Consulting LLP provides business consulting services. It offers services related to public finance, public sector management, health and social protection, information technology, financial sector, and trade and investment. The company was founded in 1996 and is headquartered in New York, NY. | Corporate Officer/Principal | - |
General Re Corp.
 General Re Corp. Multi-Line InsuranceFinance General Re Corp. is engaged in the provision of reinsurance policies. It is a holding company for global reinsurance and related operations. The firm owns General Reinsurance Corporation and holds a controlling interest in Kolnische Rückversicherungs-Gesellschaft AG. It operates through the following segments: North American Property & Casualty Reinsurance, International Property & Casualty Reinsurance, Life & Health Reinsurance and London Market Property & Casualty. The company was founded in 1921 and is headquartered in Stamford, CT. | Directeur Général | - |
Formation de R. Brian McKernan
| Bucknell University | Undergraduate Degree |
| Columbia Business School | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
General Re Corp.
General Re Corp. Multi-Line InsuranceFinance General Re Corp. is engaged in the provision of reinsurance policies. It is a holding company for global reinsurance and related operations. The firm owns General Reinsurance Corporation and holds a controlling interest in Kolnische Rückversicherungs-Gesellschaft AG. It operates through the following segments: North American Property & Casualty Reinsurance, International Property & Casualty Reinsurance, Life & Health Reinsurance and London Market Property & Casualty. The company was founded in 1921 and is headquartered in Stamford, CT. | Finance |
Courtagen Life Sciences, Inc.
Courtagen Life Sciences, Inc. Electronic Equipment/InstrumentsElectronic Technology Courtagen Life Sciences, Inc. provides proteomic and genomic products and services to the life sciences industry. It offers clinical genetic tests for developmental delay, intellectual disability, autism spectrum disorders, epilepsy and seizure disorders and mitochondrial disorders. The company was founded by Jocelyn W. Burke, Elizabeth Holland, Brendan L. McKernan, Kevin J. McKernan, Brian R. McKernan and Timothy Olcott in 1999 and is headquartered in Woburn, MA. | Electronic Technology |
Agencourt Bioscience Corp.
Agencourt Bioscience Corp. Miscellaneous Commercial ServicesCommercial Services Agencourt Bioscience Corp. provides genomic services and nucleic acid purification products. Its services enable biotechnology, pharmaceutical, government, and academic research laboratories to develop new drugs. The company was founded in July, 2000 by R. Brian McKernan, Kevin J. McKernan, and Brendan L. McKernan and is headquartered in Beverly, MA | Commercial Services |
Deloitte Consulting LLP
Deloitte Consulting LLP Miscellaneous Commercial ServicesCommercial Services Deloitte Consulting LLP provides business consulting services. It offers services related to public finance, public sector management, health and social protection, information technology, financial sector, and trade and investment. The company was founded in 1996 and is headquartered in New York, NY. | Commercial Services |
Agencourt Personal Genomics
Agencourt Personal Genomics Medical SpecialtiesHealth Technology Part of Applied Biosystems, Inc., Agencourt Personal Genomics develops genetic analysis technologies. The company is based in Beverly, MA. The company was founded by Brendan L. McKernan, R. Brian McKernan, Kevin J. McKernan. Agencourt Personal Genomics was acquired by Applied Biosystems, Inc. /Old/ from Beckman Coulter, Inc. on July 11, 2006 for $120 million. | Health Technology |
| StructuredMarkets, Inc. | |
The Courtagen Group LLC
The Courtagen Group LLC Investment ManagersFinance Courtagen Group LLC is a venture capital firm located in Charlestown, Massachusetts. | Finance |
| Analytical Life Science & Diagnostics Association | |
Nusano, Inc.
Nusano, Inc. Medical SpecialtiesHealth Technology Nusano, Inc. is a privately held medical technology company that is committed to bringing stability and innovation to the medical radioisotopes market. The company is based in Valencia, CA. The company's proprietary ion source is smaller and more efficient than existing production methods, which allows for the simultaneous manufacturing of multiple radioisotopes. Nusano's state-of-the-art production facility will open in the first quarter of 2025. The company's technologies will supply the fight against cancer and support diagnostic and therapeutic radiopharmaceutical development. Christopher P. Lowe has been the CEO of the company since 2022. | Health Technology |